Navigation Links
Training Breathing Muscles Improves Swimmer's Performance

A study conducted by researchers in University at Buffalo Center for Research and Education in Special// Environments (CRESE), shows that swimmers and scuba divers can improve their swimming endurance and breathing capacity through targeted training of the respiratory muscles.

In this pioneering work, subjects who followed a resistance-breathing training protocol (breathing load) improved their respiratory muscle strength and their snorkel swimming time by 33 percent and underwater scuba swimming time by 66 percent, compared to their baseline values. Participants randomized to a similar protocol requiring high respiratory flow rates (endurance) improved their respiratory endurance and surface and underwater swimming times by 38 percent and 26 percent, respectively.

The group randomized to a placebo-training program, conducted with the same equipment and protocol, showed no significant improvement in respiratory or swimming performance.

Results of the study appeared in the December online issue of the European Journal of Applied Physiology and will appear in printnext month.

"Specific respiratory muscle training could allow divers in the military, civilian rescue services, commercial enterprises and sport to perform better underwater," said Claes E.G. Lundgren, M.D., Ph.D., professor of physiology and biophysics in the UB School of Medicine and Biomedical Sciences and the study's senior author.

David R. Pendergast, Ed.D., professor of physiology and biophysics, adjunct professor of mechanical and aerospace engineering and CRESE director, along with his research group, were instrumental in the research.

Lundgren said that training the breathing muscles to improve the performance of swimming muscles seems counter-intuitive, but is logical physiologically.

"Typically, we think it's the muscles that move the body that are fatigued when we tire," he noted. "However, the increased work load of the b
'"/>




Page: 1 2 3 4

Related medicine news :

1. Training with weights helps building resistance
2. Weight Training Found To Be Effective In Treating MS
3. Doctor Training Undermined In Britain Due To Shortage Of Cadavers
4. Virtual Reality Simulation Could Help In Training Surgeons
5. Mind Training Can Unravel The Power Of The Subconscious Mind
6. Web-Based Training Programme For Africa Vets
7. Weight Training Improves Quality Of Life In Breast Cancer Patients
8. Gaming Giants Want A Slice Of Brain Training Pie
9. Intensive Training and Tool Kit, Indicates Adequate Preparation To Combat AIDS.
10. Indian Training Company To Train Children In Dubai, Sharjah
11. Training in Australias Medical Schools Inadequate
Post Your Comments:
(Date:10/13/2008)...ir levels were lower than Alzheimer,s patients, he...althDay News) -- Parkinson,s disease patients are ...ients to have vitamin D deficiency, say researcher...Atlanta. , They compared vitamin D levels in 10...nd 99 healthy people matched for age and other fac...
(Date:10/13/2008)...., Oct. 13, 2008 /PRNewswire/ -- The AMERIGROUP Fo... of the School for Children with,Hidden Intelligen...,training program., SCHI is a state-approved, pri...ndicapped, underprivileged children with special n... and alleviate the suffering of the,most vulnerabl...
(Date:10/13/2008)...perium(TM) Market Leading Content Rights Managemen...g the Loop on Their Content Spend, WEST CHESTER, ...ed,today that a leading global pharmaceutical manu...logy to become the primary platform for the,secure...d reporting,analytics for their new product video ...
(Date:10/13/2008)...s a significant problem in daily life, survey show.../ -- Approximately,three-quarters of people living...roblem in daily life, according to a National Psor... survey of 426 individuals with psoriasis and psor...nfluences their daily lives, shapes their,feelings...
Breaking Medicine News(10 mins):Health News:Parkinson's Patients More Prone to Vitamin D Deficiency 2Health News:AMERIGROUP Foundation Supports the School for Children with Hidden Intelligence 2Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Psoriasis Foundation Releases 2008 Study Results 2
...ter announced today the start of the EASE (Exhale ...al, multi-center clinical trial to explore an inv...ally-invasive option for those suffering with adva...n experimental procedure called airway bypass desi...
...istinction of becoming a country with the highest ...rgency facilities for heart patients could save li...Health Organisation (WHO) reports, India is likely...tack capital of the world by 2010. "Cardiac disea...
...ls Inc. and Onyx Pharmaceuticals, Inc. today annou...ntly extended overall survival in patients with h...ncer versus those taking placebo by 44%. Results w...ting of the American Society of Clinical Oncology ...
...tails of two new investigational cancer therapies ...) meeting. AZD2281 (KU-0059436) is a small molecu... PARP is an enzyme involved in Base Excision Repa...air of DNA single-stranded breaks. Inhibiting this...
Other Medicine News:Health News:Airway Bypass Treatment for Emphysema - Study 2Health News:Nexavar Significantly Extends Survival of Liver Cancer Patients 2Health News:Astrazeneca's Investigational Cancer Therapies Revealed at ASCO 2Health News:Astrazeneca's Investigational Cancer Therapies Revealed at ASCO 3
(Date:10/10/2008)...INGTON and MENLO PARK, Calif., Oct. 10 /PRNewswire...announced that it plans to present,long-term follo...rials next,week at the Cardiovascular Research Fou...diovascular Therapeutics (TCT) meeting in Washingt... studies designed to investigate,the safety and ef...
(Date:10/10/2008)...SANTON, Calif., Oct. 10 /- TriReme Me...authorized to affix the CE (Conformite,Europeenne)...M) Coronary,Stent System, a unique main vessel ste...ronary bifurcations., Representing the next gener...tem has potential use in a quarter of the 2.2 mill...
(Date:10/9/2008)...pps Translational Science Institute, Navigenics, A...lth study, SAN DIEGO, Oct. 9 /- A co...eaders have joined forces in a first-of-its-kind,r...ersonal genetic testing,on people who choose to re...risk for developing certain diseases., Sponsored ...
(Date:10/8/2008)...ona Heart Institute Pioneers Research That May Off...ct. 8 /- Nationally, over 3,000 peopl...ease on life. Sadly, only half,of those will recei...na,Heart Institute (AHI) is paving the way for how..., To view the Multimedia News Release, go to:, ht...
Breaking Medicine Technology:XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Patient Safety Technologies Closes on 242 325 Million in Equity Financing 25845 1Patient Safety Technologies Closes on 242 325 Million in Equity Financing 25845 2Replidyne Announces Restructuring of Operations 25843 1Replidyne Announces Restructuring of Operations 25843 2VaxGen Provides Financial Update Following the Filing of Its 10 Q for Second Quarter With SEC 3B Results Include 248 5 Million Charge in Respect of M 25840 1VaxGen Provides Financial Update Following the Filing of Its 10 Q for Second Quarter With SEC 3B Results Include 248 5 Million Charge in Respect of M 25840 2VaxGen Provides Financial Update Following the Filing of Its 10 Q for Second Quarter With SEC 3B Results Include 248 5 Million Charge in Respect of M 25840 3New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 1New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 2New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 3New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 4New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 5New England Journal of Medicine Publishes Phase III Results of VELCADE 28R 29 28Bortezomib 29 for Injection in Previously Untreated Multiple Myeloma 2902 6
...23, 2007 /PRNewswire-FirstCall/ -- Shire plc,annou...l system),the first and only non-oral medication ...ctivity Disorder (ADHD) in children aged 6,to 12 y...control,and tolerability, according to results of ...can Psychiatric Association (APA),annual meeting i...
...--(BUSINESS WIRE)--May 23, 2007 - Synta,Pharmaceut...mpany,focused on discovering, developing, and comm...edical conditions, today announced,that survival a...trial in metastatic melanoma of the Company,s lead...ted at the annual meeting of the,American Society ...
Other Medicine Technology:12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 212-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 312-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 412-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 512-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 612-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 712-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 812-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 9Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 2Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 3
... Volk Area Centralis® is excellent for critica...ization and changes from macular degeneration, ret...proliferative diabetic retinopathy and other retin...nt of these conditions providing excellent magnifi...
... original 130° QuadrAspheric lens has grown in...preferred wide field fundus laser lens. Its sleek ...age over competitive wide field lenses for periphe...ease of use. This lens is excellent for small pupi...
The Digital Wide Field Lens combines exceptional wide field views and high magnification. The enhanced double aspheric design and multi-layer coating provide high resolution stereo views of the retin
...ks Super VitreoFundus® provides ultra wide-fie... quick and comprehensive fundus exams at the slit ... a wide field of view through small pupils without...all pupil lenses. Delivering an incredible 124°...
Medicine Products: